By NHI Mgmt Group Editorial TeamPublished 2026-06-01Domain: Governance & RiskSource: Imprivata

TL;DR: Healthcare mobile devices now support core clinical workflows, yet they are frequently lost, misplaced, or left unaccounted for, creating security, compliance, and productivity risk, according to Imprivata. The deeper issue is not device loss itself but the lack of reliable visibility, ownership, and control across shared clinical assets.


At a glance

What this is: Healthcare mobile device loss is a visibility and accountability problem that can expose PHI, disrupt bedside workflows, and inflate operational costs.

Why it matters: IAM, PAM, and lifecycle teams need to treat shared clinical devices as governed identity-bearing assets, because loss, misassignment, and poor inventory hygiene create both security exposure and operational drag.

By the numbers:

👉 Read Imprivata's analysis of lost clinical devices and mobile asset governance


Context

Healthcare mobile device loss is a governance problem, not just a facilities problem. When shared tablets and phones support EHR access, medication administration, and secure communication, every misplaced device creates an access, data, and accountability question that traditional inventory processes often cannot answer.

The primary failure is fragmented visibility across ownership, location, and usage. In a clinical environment, that fragmentation turns routine misplacement into repeated security actions, workflow delays, and avoidable replacement costs.


Key questions

Q: What breaks when shared clinical devices are not tied to clear ownership?

A: When shared clinical devices lack clear ownership, organisations lose the ability to answer basic questions about who used the device, where it is, and what access it carried. That weakens incident response, increases unnecessary remote lock or wipe actions, and makes HIPAA decisions harder to defend.

Q: Why do lost healthcare devices create both security and workflow risk?

A: Lost healthcare devices interrupt bedside work because clinicians cannot access charts, medication tools, or communication systems at the right time. They also create security risk because any device that still carries sessions or credentials can expose PHI until the organisation verifies its status.

Q: How do organisations know whether mobile asset controls are actually working?

A: They should measure how quickly missing devices are recovered, how often devices are unassigned, and whether remote containment actions are based on verified state. If the organisation still replaces devices before confirming their status, the control environment is reactive rather than governed.

Q: Who is accountable when a shared clinical device exposes patient data?

A: Accountability should sit with the operational owner of the device fleet, the clinical team using it, and the security function that defines response thresholds. In practice, the organisation is accountable for proving that its mobile asset governance was strong enough to limit PHI exposure and operational disruption.


Technical breakdown

Why shared clinical devices become unmanaged identity assets

A shared hospital phone or tablet is not just hardware. It is also a bearer of application sessions, cached credentials, and access pathways into protected systems. When ownership is unclear, the device effectively becomes a floating trust boundary. Traditional MDM can tell you a device is enrolled, but not whether it is available, in use, or abandoned in a patient room. That gap matters because identity risk follows the device, not the asset record. Practical implication: inventory must be tied to operational status and user accountability, not just serial numbers.

Practical implication: tie device records to live ownership and usage state, not just asset registration.

Why MDM alone does not solve mobile asset visibility

Mobile device management secures configuration and policy, but it does not provide a complete operational picture. Healthcare teams still need real-time context to distinguish misplaced devices from truly lost ones, and to know when a remote lock or wipe is proportionate. Without that context, IT treats every missing device as a potential incident, which increases support load and can disrupt care unnecessarily. Asset management adds the missing layer by tracking where devices are, who used them, and whether they are idle, missing, or recovered. Practical implication: pair MDM with location and utilization telemetry.

Practical implication: combine MDM with location and utilisation telemetry before triggering containment actions.

How visibility changes the risk model for PHI exposure

A lost device creates uncertainty that is itself a risk signal. Even when encryption exists, healthcare organisations still face HIPAA pressure because they cannot quickly prove whether the device held active data, who last used it, or whether credentials remain accessible. That uncertainty drives overreaction, underreaction, or both. Real-time asset visibility reduces that ambiguity by narrowing the decision space and shortening recovery time. It also gives leadership better evidence for replacement decisions, utilization planning, and compliance reporting. Practical implication: design controls to reduce uncertainty, not just to harden endpoints.

Practical implication: build controls that shorten uncertainty windows and support defensible HIPAA decisions.


Threat narrative

Attacker objective: The objective is to exploit unaccounted-for clinical device access to reach protected patient data or interrupt operations before controls can respond.

  1. Entry occurs when a shared clinical device is lost, left in a patient room, or taken offsite and not returned, creating an unmonitored access point into healthcare workflows.
  2. Escalation follows when the missing device still carries application sessions or access to protected health information, allowing unauthorized viewing or misuse before the loss is detected.
  3. Impact is exposure of PHI, workflow disruption, remote lock or wipe actions, replacement spending, and potential HIPAA reporting and audit consequences.

Read our 52 NHI Breaches Analysis report for a comprehensive view of breaches impacting Non-Human Identities including AI Agents.


NHI Mgmt Group analysis

Lost clinical devices are governed identities, not just missing assets. In healthcare, a shared phone or tablet often carries active access into clinical systems, which makes ownership and status governance as important as physical tracking. The control failure is the absence of a reliable link between the device, the user, and the current access state. Practitioners should treat each device as a lifecycle-managed access object, not a disposable endpoint.

Device loss exposes a standing-access model that healthcare teams have normalised for convenience. Shared devices are frequently kept usable across shifts because speed matters at the bedside, but that convenience creates persistent uncertainty about who has access and when. The governance gap is not merely weak inventory hygiene. It is the assumption that access remains acceptable after the original user or location context has changed. The implication is that clinical mobility programmes need tighter accountability than generic enterprise endpoint fleets.

Identity blast radius: when a lost device is also a shared access point, the security problem expands from hardware replacement to patient-data exposure, credential reuse, and operational interruption. That makes device recovery time, session state, and last-known usage more important than raw device count. Practitioners should prioritise controls that reduce the blast radius of each missing device before the next one goes missing.

Healthcare leaders should reframe mobile asset management as an access-governance control. The article shows that device abundance does not equal operational resilience when ownership, utilisation, and recovery are opaque. This is a lifecycle issue across provisioning, assignment, recovery, and retirement. Teams that manage those transitions well will have a stronger compliance posture and less waste.

The market signal is that visibility is becoming the core control plane for clinical mobility. As mobile workflows spread, organisations need a single operational view that connects device state to security and care delivery decisions. That aligns with NIST Cybersecurity Framework 2.0 thinking around identify, protect, detect, respond, and recover, but the practical test is whether the organisation can answer where the device is, who used it, and what access it carried. Practitioners should measure mobility governance by recoverability and accountability, not by enrollment alone.

From our research:

What this signals

Clinical mobility programmes are converging with identity governance whether teams acknowledge it or not. Once shared devices carry application sessions, the practical control question becomes how quickly the organisation can recover access state, not simply where the hardware last appeared. The strongest programmes will connect operational telemetry to lifecycle controls and report on recoverability as a governance metric.

Identity blast radius: the useful metric in healthcare mobile environments is not device count but how much access each missing device can expose before it is contained. Organisations that still treat replacement cost as the primary concern are missing the larger governance issue, which is the speed and quality of access-state recovery.

Mobile workflows are also pushing healthcare teams toward tighter alignment with NIST Cybersecurity Framework 2.0, especially around detect, respond, and recover. The test is whether the programme can distinguish a misplaced device from a compromised one fast enough to avoid unnecessary disruption and protect PHI.


For practitioners

  • Map each shared device to a named owner and clinical purpose Require an accountable business owner, last-known user, and current location state for every shared tablet and phone. If a device cannot be tied to a named operational role, it should not remain in circulation.
  • Join MDM data to real-time location and utilization signals Correlate enrollment records with live telemetry so IT can distinguish idle, misplaced, and truly missing devices before locking or wiping them. That reduces unnecessary disruption while improving recovery confidence.
  • Define a missing-device response path that starts with access state Before remote wipe or replacement, check whether the device still has active sessions, cached credentials, or direct access to patient data. The decision should be based on current access state, not only on physical absence.
  • Measure recovery time and accountability gaps, not just inventory counts Track how long it takes to find a missing device, how often devices reappear, and how many remain unassigned. Those metrics reveal whether device governance is working or merely producing more hardware.

Key takeaways

  • Lost healthcare devices are a governance problem because they can carry live access, not just hardware value.
  • The scale of the issue is visible in the $822 average replacement cost, but the larger cost is workflow disruption and PHI exposure.
  • Shared-device programmes improve when ownership, location, and session state are managed together rather than as separate controls.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

OWASP Non-Human Identity Top 10 address the attack and risk surface, while NIST CSF 2.0 and NIST Zero Trust (SP 800-207) set the governance and control requirements practitioners need to meet.

FrameworkControl / ReferenceRelevance
NIST CSF 2.0PR.AC-4Shared device access depends on clear authorization and accountability.
NIST Zero Trust (SP 800-207)PT-2Zero trust requires better device state awareness before access decisions.
OWASP Non-Human Identity Top 10NHI-03Mobile devices often carry credentials and sessions that need lifecycle control.

Treat device-borne credentials as managed non-human identities and define recovery and revocation steps.


Key terms

  • Shared Clinical Device: A shared clinical device is a phone, tablet, or similar endpoint used by multiple staff members to support care delivery. In governance terms, it is an access-bearing asset because it can hold sessions, cached credentials, and application pathways that must be managed across shifts and locations.
  • Mobile Asset Visibility: Mobile asset visibility is the ability to know where a device is, who last used it, and whether it is active, idle, misplaced, or missing. It is more useful than simple inventory because it turns asset tracking into a decision input for security and clinical operations.
  • Identity Blast Radius: Identity blast radius is the amount of damage that can follow when a device, credential, or session is lost or misused. For shared clinical devices, it includes patient data exposure, workflow interruption, and unnecessary containment actions, so the goal is to shrink both access scope and recovery time.
  • Device Lifecycle Governance: Device lifecycle governance is the set of controls that cover provisioning, assignment, use, recovery, and retirement of shared endpoints. It matters because a device that is managed only at enrollment can still become risky if ownership, status, and decommissioning are not kept current.

Deepen your knowledge

Healthcare mobile device governance is covered in our NHI Foundation Level course, the industry's only accredited NHI security programme. If you are building controls for shared clinical devices and their access state, it is worth exploring.

This post draws on content published by Imprivata: Mobile device loss in healthcare and the case for asset management. Read the original.

NHIMG Editorial Note
Published by the NHIMG editorial team on 2026-06-01.
NHI Mgmt Group — the independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org